China's EV buying subsidies for 2025 end in parts of Xian, local media says
Shaanxi Daily
reported on Tuesday.
Some Chinese cities, including Zhengzhou and Luoyang, suspended trade-in subsidies for car buyers because the first round of funding allocated by
Beijing
for the scheme was running out,
Reuters
reported in June.
The state planner and finance ministry said last month that consumer trade-in subsidies for the remainder of the year would be issued in July and October respectively.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
40 minutes ago
- Time of India
US-Japan deal brings tariff clarity: 15% cap averts August duties; EU and China face pressure as next deadlines loom
A landmark trade deal between the US and Japan has set a new benchmark for global tariff negotiations, as economists say the 15% cap agreed for auto and goods tariffs could become the new normal in ongoing trade talks with other key US partners. Under the agreement, tariffs on Japanese auto imports to the US will drop from 27.5% to 15%, while levies on other goods that were set to rise to 25% from August 1 will also be cut to 15%, Reuters reported. The deal, which includes investment and lending commitments, is one of the most significant trade pacts signed by US President Donald Trump, who has imposed a series of steep tariffs on dozens of trading partners this year The deal relieves markets and raises pressure on other major economies, including the European Union and China, both of which face looming August deadlines to conclude similar agreements or risk the reimposition of punitive tariffs. 'Average tariffs for the US were around 2.5% for 2024; currently, they stand around 17%,' said Mohit Kumar of Jefferies, referencing the spike in duties following Trump's 'Liberation Day' trade policy shift in April. 'Our base case remains that when the dust settles, we could see average tariffs around 15%, though recent deals suggest that this number could be slightly higher,' Kumar was quoted as saying by Reuters. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe the Price of These Dubai Apartments Binghatti Developers FZE Get Offer Undo 'While a negative from a macro point of view, the world can live with 15% or so tariffs.' Markets cheer clarity, automakers lead gains Relieved by the clarity brought by the US-Japan pact, Japan's Nikkei 225 index rose 3.5%, while European automakers with major US exposure also rallied. Volvo Car surged over 10%, while Porsche, BMW, Mercedes-Benz and Volkswagen gained between 4% and 7%. 'It looks like the benchmark for major economies is going to be 10–15%, and a somewhat higher level for smaller economies,' said Derek Halpenny, head of research at MUFG in London. Deutsche Bank's Jim Reid noted the move 'helped to ease investor fears that tariffs are about to snap back higher on August 1,' but cautioned that significant threats remain. 'The threat of much higher tariffs still remains for several large economies, including the 30% on the EU, 35% on Canada and 50% on Brazil,' he said, quoted Reuters. EU and China next in line The European Union, which negotiates on behalf of its 27 member states, faces the threat of 30% US tariffs by August 1. While EU negotiators initially aimed for a 10% rate, expectations have now shifted toward a higher outcome. China, too, is on the clock. Without a deal by August 12, tariffs could snap back to 145% on the US side and 125% on the Chinese side—raising the stakes dramatically for both economies. 'The US-Japan deal will put more pressure on other major Asia exporters to secure better deals,' ING noted in a research comment. 'We've already seen trade deals with the Philippines and Indonesia. Before August 1, there should be more deals struck with Asian exporters.' The deal also helped ease longer-term US inflation expectations, suggesting that successful trade pacts could help the Federal Reserve regain room to cut interest rates later this year. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Mint
an hour ago
- Mint
India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies
The India-UK free trade agreement, signed on Thursday, is expected to open up new opportunities for Indian pharmaceutical and medical device makers. The deal is also expected to improve access to medical devices from the UK in India. Medical device manufacturers anticipate an increase in trade between the two countries but are awaiting clarity on non-tariff measures and on whether regulatory processes will be streamlined. 'Previously, medical devices imported into the UK were duty-free, so tariff restrictions were not an issue but regulatory approval costs and time were a challenge,' said Rajiv Nath, forum coordinator of industry body Association of Indian Medical Device Industry (Aimed). The body had previously sought recognition of regulatory approvals from the CDSCO or the Quality Council of India's voluntary Indian Certification for medical devices to fast-track approvals by the UK's Medicines and Healthcare products Regulatory Agency (MHRA). 'We look forward to an update on this,' said Nath. However, medtech manufacturers are also seeking strict monitoring of imports to India, to prevent other countries rerouting products into India through the UK. Mint had previously reported that domestic manufacturers raised concerns over the possibility of Chinese-origin products being routed through the UK to exploit the zero-tariff provisions under the FTA. India levies about 7.5% import duties on medical devices from the UK, which are expected to come down in a phased manner after the deal, Nath said. In 2024, medical device exports to the UK increased by 13% year-on-year to ₹ 1,015 crore, while imports from the UK rose 36% to ₹ 2,295 crore, according to Exim data. 'It not only strengthens trade ties but also opens new avenues for advanced technology collaborations between Indian and UK companies,' Himanshu Baid, managing director of Poly Medicure Ltd, said in a statement. 'With India exporting medical devices worth approximately $115 million to the UK, one of our top 10 export destinations, this agreement is poised to further boost our presence,' he added. The trade deal is also expected to open up the market for India's generic drugmakers. 'As per the indications, the pharma sector will have opportunities to supply affordable and quality assured medicine contributing to better patient care in the UK,' said Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA). 'We are awaiting further details to identify specific areas where these opportunities can be effectively leveraged,' he added. Generic players like Lupin, Biocon, Dr. Reddy's Laboratories and Wockhardt, which have exposure to the UK market, could stand to benefit.
Time of India
an hour ago
- Time of India
OpenAI plans to launch GPT-5 in August: Report
OpenAI is gearing up to launch GPT‑5 in early August 2025, following a delay for additional testing. In April, Altman announced a shift in the company's AI model release schedule, revealing that intermediate models known as 'o3' and 'o4-mini' will be launched in the coming weeks, ahead of the much-anticipated GPT-5 rollout. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Sam Altman-led OpenAI is planning to launch its much awaited advanced artificial intelligence (AI) model GPT 5 in August, according to a report by The news comes after Altman 's statement to make free copy of GPT-5 available to everybody. 'I am very interested in what it means to give everybody on Earth a free copy of GPT-5, running for them all the time," he also shared plans to roll out GPT-5 on microblogging platform X on July 19. However, he said it is not yet capable of solving the very hardest math problems, such as those in the International Math Olympiad (IMO).'We are releasing GPT-5 soon but want to set accurate expectations: this is an experimental model that incorporates new research techniques we will use in future models,' he said.'We think you will love GPT-5, but we don't plan to release a model with IMO gold level of capability for many months,' he April, Altman announced a shift in the company's AI model release schedule, revealing that intermediate models known as 'o3' and 'o4-mini' will be launched in the coming weeks, ahead of the much-anticipated GPT-5 this month, Reuters reported that the company is also preparing to launch an AI-powered web browser that would directly compete with Google Chrome. This follows the recent release of ChatGPT Agent , a new tool that can perform tasks on users' computers autonomously.
